| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.1M | — | -16.1% |
| SG&A Expense | $1.6M | — | +8.2% |
| Operating Income | -$2.5M | — | -7.7% |
| Pre-tax Income | -$2.4M | — | -16.8% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$2.4M | — | -10.3% |
| EPS (Basic) | -$0.58 | — | -11.5% |
| EPS (Diluted) | -$0.58 | — | -11.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.0M | +26.0% | +190.5% |
| Short-term Investments | $2.9M | -65.2% | -85.7% |
| Accounts Receivable | $1.5M | +1.4% | +15.4% |
| Current Assets | $18.7M | -14.1% | -31.1% |
| Total Assets | $21.2M | -12.5% | -37.6% |
| Current Liabilities | $2.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | -16.9% |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | $5.4M | — | +102.1% |
| Financing Cash Flow | -$842 | — | — |
| Free Cash Flow | -$3.2M | — | -17.1% |
| -46.9% |
| Total Liabilities | $7.3M | -10.3% | -29.3% |
| Stockholders' Equity | $13.9M | -13.6% | -41.2% |